Media Coverage

The Great LER Debate


Low Endotoxin Recovery (LER) has been a topic of interest for almost three years, but not much changed in that time. John Dubczak, General Manager of Charles River's Microbial Solutions, discusses in Outsourced Pharma.

Charles River Labs to hire 300 locally in coming year; acquires pill-making capability


Charles River Laboratories is planning to hire up to 300 people in the next year in Massachusetts to work in its newly reopened drug safety lab in Shrewsbury. The news comes as the Wilmington-based company bought Ohio-based WIL Research for $585 million in hopes of expanding its drug safety testing capabilities while opening up the opportunity to manufacture pills.

Charles River to Acquire WIL Research


Charles River Laboratories has entered a definitive agreement to acquire WIL Research for approximately $585 million in cash, subject to customary closing conditions. WIL Research provides safety assessment and contract development and manufacturing (CDMO) services to biopharmaceutical, agricultural, and industrial chemical companies globally.

Charles River Labs to Acquire WIL Research for $585M


Charles River Laboratories has agreed to acquire WIL Research for approximately $585 million cash, in a deal the buyer said will enhance its global footprint, scientific capabilities, and access to growing market segments.

Charles River Laboratories to acquire WIL Research


Charles River Laboratories announced it will pay $585 million in cash to acquire WIL Research Laboratories LLC, a deal that will expand its reach in Europe and provide a toehold in contract manufacturing for biopharmaceutical companies.

Displaying results 1-10 (of 71)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8  >  >|